GHW International (9933) AI Stock Analysis

• Market Cap: HK$2.00B
• Dividend Yield: N/A
• Average Volume (3M): 395.02K
• Price to Earnings (P/E): 115.3
• Beta (1Y): 1.44
• Revenue Growth: 11.08%
• EPS Growth: 147.89%
• Country: HK
• Employees: 1,120
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals
• EPS (TTM): <0.01
• Shares Outstanding: 1,009,500,000
• 10 Day Avg. Volume: 231,200
• 30 Day Avg. Volume: 395,016
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: HK$1.50
• Price Target Upside: -26.11% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 48 Neutral
• Price Target: HK$1.50 ▼(-26.11% Downside)

GHW International's overall stock score is primarily impacted by its weak financial performance and high valuation concerns. The technical analysis suggests a bearish trend, further weighing down the score. The lack of earnings call and corporate events data means these factors did not influence the score.

GHW International Business Overview & Revenue Model

Company Description

GHW International, an investment holding company, manufactures and sells chemical and pharmaceutical products in the People's Republic of China, Europe, Vietnam, rest of Asia, and internationally. It operates through four segments: Polyurethane Materials, Animal Nutrition Chemicals, Fine Chemicals, and Pharmaceutical Products and Intermediates. The Polyurethane Materials segment offers polymeric methylene diphenyl diisocyanate and toluene diisocyanate, and polymer polyether for use in cushion foams, interior components, and other lightweight automotive parts. The Animal Nutrition Chemicals segment provides choline chloride and betaine used in feeds for poultry and livestock. The Fine Chemicals segment offers carboxylic acids, solvents, resins, and oleochemicals used in the paint and synthesis of dyes, production of lubricants, emulsifiers, cosmetics, flavors and fragrances, and feed additives. The Pharmaceutical Products and Intermediates segment produces and sells isooctanoic acid and diethyl sulfate for use in paint drier, fungicide, preservative and pharmaceutical raw materials, synthesis of dyes, pesticides, and pharmaceutical intermediates; and iodine and iodine derivatives, and pharmaceutical products, such as cefpodoxime dispersible tablets. GHW International was founded in 1995 and is headquartered in Nanjing, the People's Republic of China.

How the Company Makes Money

GHW International makes money primarily through the sale and distribution of its chemical products across various sectors. The company's revenue streams include the production and sale of specialty chemicals, which are used in numerous applications such as pharmaceuticals, food, and industrial manufacturing. Additionally, GHW International generates income through its agrochemical products, which are essential for agricultural productivity and efficiency. The company also benefits from partnerships with other firms in the chemical industry, leveraging collaborations to expand its market reach and enhance product offerings. Key factors contributing to its earnings include its strong supply chain, innovative product development, and adherence to environmental and regulatory standards.

GHW International Financial Statement Overview

Summary

GHW International shows revenue growth and operational efficiency improvements, but high leverage and weak cash flow management pose concerns. Profitability remains low, with a net profit margin of 0.33% and significant leverage indicated by a high debt-to-equity ratio.

Income Statement

GHW International's revenue has shown a steady growth trajectory, with a notable increase from 2023 to 2024. Gross profit margin improved slightly to 10.12% in 2024, indicating better cost management. However, the net profit margin remains low at 0.33%, affected by high operating costs. EBIT and EBITDA margins also show improvement, reflecting operational efficiency gains.

Balance Sheet

The company's debt-to-equity ratio is relatively high, indicating significant leverage, which could pose risks in adverse conditions. Return on equity has improved but remains modest at 2.18% in 2024. The equity ratio, at 28.62%, suggests a balanced but cautious financial structure with room for strengthening the equity base.

Cash Flow

GHW International's cash flow position is weak, with zero reported free cash flow in 2024, indicating potential liquidity challenges. The lack of positive operating cash flow growth and free cash flow to net income ratio suggests potential inefficiencies in cash generation and usage.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	3.86B	3.22B	3.38B	2.83B	2.10B
Gross Profit	391.02M	336.98M	657.90M	476.12M	273.27M
EBITDA	39.42M	17.34M	329.44M	176.11M	31.84M
Net Income	12.75M	2.72M	274.63M	130.71M	-5.17M
Balance Sheet
Total Assets	2.05B	1.74B	1.68B	1.37B	1.02B
Cash, Cash Equivalents and Short-Term Investments	101.73M	77.84M	103.30M	58.02M	62.56M
Total Debt	862.35M	718.32M	663.43M	700.00M	572.24M
Total Liabilities	1.42B	1.16B	1.08B	1.03B	816.25M
Stockholders Equity	585.78M	581.42M	602.62M	339.08M	205.50M
Cash Flow
Free Cash Flow	-63.40M	-19.81M	-40.29M	-337.51M	-213.31M
Operating Cash Flow	61.04M	120.07M	234.08M	-122.53M	-125.22M
Investing Cash Flow	-158.51M	-140.43M	-197.72M	-164.18M	-150.75M
Financing Cash Flow	126.98M	-4.97M	9.07M	284.99M	303.34M

GHW International Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2.03
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:9933, the sentiment is Positive. The current price of 2.03 is below the 20-day moving average (MA) of 2.04, above the 50-day MA of 1.76, and above the 200-day MA of 1.85, indicating a neutral trend. The MACD of 0.06 indicates Positive momentum. The RSI at 56.05 is Neutral, neither overbought nor oversold. The STOCH value of 45.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:9933.

GHW International Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2198	65 Neutral	3.01B	4.00	10.84%	―	9.20%	213.87%
1702	63 Neutral	869.32M	12.12	4.69%	2.58%	-8.51%	-68.34%
0609	54 Neutral	1.27B	20.44	―	3.45%	-5.29%	-32.47%
9933	48 Neutral	HK$2.00B	115.34	2.59%	―	11.08%	147.89%
0954	45 Neutral	174.80M	-2.15	-11.70%	―	-17.15%	30.94%
0827	45 Neutral	204.95M	-0.34	-125.34%	―	-22.72%	-212.73%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%

GHW International Corporate Events

GHW International Announces Change in Share Registrar

GHW International, a company incorporated in the Cayman Islands, has announced a change in its Hong Kong Share Registrar and Transfer Office. Effective from July 7, 2025, Tricor Investor Services Limited will take over these responsibilities. This change is significant for shareholders as it affects where share registration and transfer applications are processed, potentially impacting the operational efficiency and stakeholder interactions.

GHW International Successfully Passes All AGM Resolutions

GHW International announced that all resolutions proposed at its Annual General Meeting held on 27 May 2025 were passed by shareholders via poll. The meeting saw participation from shareholders holding approximately 54.92% of the issued shares, and all directors attended either in person or electronically. The successful passing of these resolutions indicates strong shareholder support and could positively impact the company’s governance and strategic initiatives.